Round out your CMHC educational experience by attending Professional Medical Education/Product Theater symposia focused on novel therapies. These non-certified activities are planned solely by the sponsoring organizations/companies. There are no additional fees to attend once you have registered for the 13th Annual Congress and meals or refreshments may be provided. Register for the 13th Annual CMHC today and attend these activities.


 ‌

Non-CME Lunch Symposium · Wednesday, October 24, 2018 · 12:00pm – 1:00pm

Sponsored by Amgen, Inc.


 ‌

Non-CME PME Light Bites · Wednesday, October 24, 2018 · 4:15pm – 5:15pm

Gaining Access to PCSK9 Inhibitors: Using a Novel Mobile App

Faculty: Seth J. Baum, MD, FASPC; Howard S. Weintraub, MD, FASPC

Learn how to access PCSK9 Inhibitors using the ASPC novel Mobile App! This innovative tool includes a simple-10-step approach, single page prior authorization and appeal letters published by the ASPC, the Association of Clinical Endocrinologists and others, valuation models of drugs, case studies, references to key papers, names of “best and worst” insurance companies in each state, links to advocacy sites, information on specialty pharmacies, and so much more.

Sponsored by the American Society for Preventive Cardiology


 ‌

Non-CME PME Light Bites · Wednesday, October 24, 2018 · 5:30pm – 6:30pm

Sponsored by Janssen Pharmaceuticals, Inc.


 ‌

Non-CME Dinner Symposium · Wednesday, October 24, 2018 · 6:45pm – 7:45pm

Cardiovascular Disease Burden in the US and Clinical Evaluation of VASCEPA® (icosapent ethyl)

Faculty: Robert S. Busch, MD, FACE

Hear from an expert about Cardiovascular Disease Burden in the US and Clinical Evaluation of VASCEPA® (icosapent ethyl). Despite the benefits of LDL-C lowering, many patients on statin therapy remain at risk. In this presentation, data and perspectives on the role of high triglycerides as a marker of increased cardiovascular risk in patients with statin-controlled LDL-C will be discussed. The clinical development program and safety for pure EPA VASCEPA will be reviewed.

Visit the Amarin booth #414 for more information.

Financial support for this program is provided by Amarin Pharma, Inc.


 ‌

Non-CME PME Light Bites · Thursday, October 25, 2018 · 6:10pm – 7:10pm

Sponsored by Akcea Therapeutics


 ‌

Non-CME Dinner Symposium · Friday, October 26, 2018 · 7:15pm – 8:15pm

Advancements in the Management of Patients with Type 2 Diabetes: Results from a Large Cardiovascular Outcomes Trial

Faculty: Ronald D’Agostino, DO, FACC, FACP

Sponsored by Novo Nordisk